1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride CAS:70918-74-0

1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride, also known as MBDB, has several potential uses in the field of pharmaceuticals and research. This compound is of interest due to its unique chemical structure and properties, which make it valuable for various applications. In pharmaceutical research, 1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride is studied as a potential intermediate for the synthesis of novel drugs. Its structural features may contribute to the development of new pharmaceutical compounds with desired pharmacological activities, making it an important building block for medicinal chemistry. Furthermore, this compound is utilized for scientific investigations into the structure-activity relationships of biologically active molecules. Researchers use it as a reagent to study the biological pathways and mechanisms of action associated with certain drug targets. By modifying the chemical structure of 1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride, scientists can explore how these modifications affect the compound's interactions with biological systems and potentially identify new therapeutic agents. Moreover, 1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride is employed in the synthesis of reference standards and analytical tools for drug testing and analysis. Its use in this capacity supports quality control measures in pharmaceutical production and ensures accurate identification and quantification of related compounds in complex mixtures. Overall, 1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazinehydrochloride holds promise for pharmaceutical research, drug discovery, and analytical applications, contributing to advancements in medicinal chemistry and pharmacology.